V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006729 | 290005093 | 1.6 | 80 | Palliative (P) | 2018-08-20 | 2018-08-20 | Cisplatin 100 + RT(H&N) 1 day | N | N | 290020555 | INTERAACT TRIAL |
| 290006730 | 290005094 | 1.75 | 58.2 | Curative (C) | 2015-11-01 | 2017-02-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020560 | MITOMYCIN |
| 290006732 | 290005095 | 1.89 | null | Curative (C) | 2015-01-15 | 2015-01-24 | Capecitabine | N | Y | 290020564 | CETUXIMAB |
| 290006733 | 290005096 | 1.82 | 64.1 | Palliative (P) | 2016-10-04 | 2016-11-15 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | 290020575 | GEMCITABINE |
| 290006734 | 290005097 | 1.61 | 56.7 | Palliative (P) | 2018-03-06 | 2018-03-13 | Sunitinib | 02 | N | 290020576 | CARBOPLATIN + ETOPOSIDE |
| 290006735 | 290007148 | 1.74 | 109 | Palliative (P) | 2017-04-26 | 2017-05-18 | INTERAACT trial | 2 | N | 290020580 | ECX |
| 290006736 | 290005099 | 1.63 | 67.55 | Curative (C) | 2014-07-13 | 2015-04-02 | Trastuzumab Subcutaneous | 2 | N | 290020586 | CISPLATIN + RT |
| 290006737 | 290005100 | 1.81 | 80.4 | Palliative (P) | 2015-07-15 | 2015-07-20 | Trabectedin | N | N | 290020592 | TRIAL |
| 290006738 | 290005101 | 1.57 | 67.3 | Curative (C) | 2016-11-29 | 2016-11-29 | ECX | 02 | Y | 290020596 | CAPECITABINE |
| 290006739 | 290005104 | 1.77 | 57 | Curative (C) | 2017-04-18 | 2017-04-26 | Capecitabine + Mitomycin | Y | N | 290020599 | CARBOPLATIN + RT |
| 290006740 | 290005105 | null | null | Adjuvant (A) | 2016-01-18 | 2016-02-14 | FLUOROURACIL + MITOMYCIN | N | Y | 290020601 | CAPECITABINE |
| 290006741 | 290005106 | 1.76 | 105.5 | Curative (C) | 2016-05-17 | 2016-05-17 | IGEV R | null | null | 290020607 | CISPLATIN + RT |
| 290006742 | 290005107 | 1.84 | 72 | Curative (C) | 2016-04-05 | 2017-10-22 | LANREOTIDE | 02 | N | 290020608 | CARBOPLATIN |
| 290006743 | 290005109 | 1.77 | 70.9 | Palliative (P) | 2016-06-27 | 2016-06-30 | ECarboX | 02 | N | 290020614 | PACLITAXEL |
| 290006744 | 290007150 | 1.75 | 63.7 | Not known (9) | 2017-07-04 | 2017-07-14 | Y-90 | N | N | 290020614 | LANREOTIDE |
| 290006745 | 290007150 | 1.75 | null | Palliative (P) | null | 2018-04-15 | Cetuximab 7 day (>Cycle 2) | 2 | N | 290020614 | CETUXIMAB |
| 290006746 | 290007150 | 1.72 | 48.1 | Adjuvant (A) | 2015-11-08 | 2016-03-18 | Capecitabine + Cisplatin | N | N | 290020614 | CISPLATIN + RT |
| 290006747 | 290005111 | 1.62 | 72.7 | Curative (C) | 2018-03-09 | 2018-03-28 | Hydroxycarbamide | 02 | null | 290020628 | CAPECITABINE + OXALIPLATIN |
| 290006748 | 290005112 | 1.87 | 77 | Palliative (P) | 2017-04-28 | 2017-04-28 | Cisplatin + Radiotherapy | 02 | N | 290020635 | CAPECITABINE + OXALIPLATIN |
| 290006749 | 290007975 | 1.72 | 90.9 | Adjuvant (A) | 2018-02-16 | 2018-03-20 | LANREOTIDE | 02 | N | 290020636 | CAPECITABINE + OXALIPLATIN |
| 290006750 | 290007975 | 1.6 | 76.5 | Palliative (P) | null | 2016-06-20 | Trial Unspecified | 2 | null | 290020636 | SUNITINIB |
| 290006751 | 290005118 | null | 81 | Curative (C) | 2014-12-17 | 2018-01-17 | CETUXIMAB | 02 | N | 290020642 | CISPLATIN + RT |
| 290006752 | 290005119 | 1.68 | 77 | Curative (C) | 2017-10-14 | 2017-10-14 | CAPECITABINE + OXALIPLATIN | 02 | N | 290020647 | CISPLATIN + RT |
| 290006753 | 290005121 | 1.58 | 52.3 | null | 2015-04-16 | 2015-10-08 | Trial Unspecified | 02 | N | 290020655 | LANREOTIDE |
| 290006754 | 290005122 | 1.87 | 90.25 | Palliative (P) | null | 2016-08-20 | Irinotecan | N | null | 290020656 | CARBOPLATIN + ETOPOSIDE |
| 290006755 | 290007155 | 1.56 | 78.1 | null | 2018-10-10 | 2018-10-10 | CAPECITABINE + IRINOTECAN | 02 | N | 290020658 | TRIAL |
| 290006756 | 290007155 | 1.53 | 78.7 | Palliative (P) | 2016-02-23 | 2016-02-23 | CARBOPLATIN | 02 | N | 290020658 | LANREOTIDE |
| 290006757 | 290005123 | 1.55 | null | Curative (C) | 2017-03-04 | 2017-03-15 | Capecitabine + Mitomycin | N | Y | 290020664 | CETUXIMAB + RT |
| 290006758 | 290005126 | 1.73 | 74.9 | Curative (C) | 2014-02-16 | 2014-02-17 | Cetuximab + Radiotherapy Load | N | Y | 290020664 | CAPECITABINE + CISPLATIN + RT |
| 290006759 | 290005127 | 1.71 | null | Curative (C) | 2017-08-22 | 2017-08-31 | Capecitabine + Mitomycin | N | N | 290020674 | CAPECITABINE + MITOMYCIN + RT |
| 290006760 | 290005127 | null | 58.8 | Adjuvant (A) | 2015-08-23 | 2015-08-23 | Bortezomib +/- Dexamethasone | null | null | 290020674 | CARBOPLATIN + RT |
| 290006761 | 290005128 | 1.59 | 50 | Curative (C) | null | 2018-12-04 | MCX | N | N | 290020679 | CARBOPLATIN |
| 290006762 | 290005129 | 1.76 | 86 | Palliative (P) | 2013-09-15 | 2013-10-02 | CAPECITABINE + OXALIPLATIN | N | N | 290020680 | GEMCITABINE |
| 290006763 | 290005129 | 1.69 | null | Disease modification (D) | 2015-01-23 | 2015-02-06 | Carboplatin AUC 2 - 5 | N | N | 290020680 | BCG |
| 290006764 | 290005130 | 0 | 60.8 | Curative (C) | 2014-08-08 | 2014-08-14 | Capecitabine + Cisplatin | 02 | N | 290020688 | CARBOPLATIN + PACLITAXEL |
| 290006765 | 290005132 | null | 63 | Curative (C) | 2014-12-15 | 2015-05-10 | Capecitabine + Oxaliplatin 21day | 2 | N | 290020691 | CARBOPLATIN + PACLITAXEL |
| 290006766 | 290005134 | 1.77 | 61 | Curative (C) | 2016-04-11 | 2016-05-27 | Capecitabine 42days + RT | N | Y | 290020691 | CAPECITABINE |
| 290006767 | 290005135 | 1.71 | 66.4 | Curative (C) | null | 2016-09-26 | MITOMYCIN | null | N | 290020706 | CARBOPLATIN + ETOPOSIDE |
| 290006768 | 290007161 | 1.76 | 65.1 | Curative (C) | 2017-10-12 | 2017-12-05 | Gemcitabine + Capecitabine | N | N | 290020708 | CETUXIMAB + CISPLATIN + FU |
| 290006769 | 290007162 | null | 72.7 | Palliative (P) | 2014-07-21 | 2014-07-26 | Carboplatin + Paclitaxel (3 weekly) | null | N | 290020709 | IRINOTECAN |
| 290006770 | 290005138 | 1.64 | 88.75 | Curative (C) | 2017-11-26 | 2017-11-30 | CAP + RT | 02 | null | 290020709 | CISPLATIN + RT |
| 290006771 | 290005138 | 1.6 | 84.4 | Adjuvant (A) | 2014-06-25 | 2014-06-25 | Carboplatin AUC 2 - 5 | N | N | 290020709 | CAPECITABINE |
| 290006772 | 290005138 | null | 58.9 | Palliative (P) | 2017-08-09 | 2017-08-15 | Trial Unspecified | null | N | 290020709 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290006773 | 290005138 | 1.69 | 61.9 | Curative (C) | 2017-07-13 | 2017-08-30 | LANREOTIDE | 02 | N | 290020709 | CARBOPLATIN |
| 290006774 | 290008458 | null | 87.5 | null | 2014-04-02 | 2014-04-02 | LANREOTIDE | 02 | Y | 290020726 | CARBOPLATIN + ETOPOSIDE |
| 290006775 | 290005139 | null | 90.6 | Adjuvant (A) | 2016-07-21 | 2016-09-06 | Carboplatin + Paclitaxel (3 weekly) | null | N | 290020727 | CISPLATIN + RT |
| 290006776 | 290005140 | 1.76 | 0 | Palliative (P) | 2017-12-15 | 2018-01-12 | Trial Unspecified | N | N | 290020733 | REGORAFENIB |
| 290006777 | 290005141 | null | null | Adjuvant (A) | 2016-07-18 | 2016-07-24 | IGEV R | N | N | 290020741 | CISPLATIN + RT |
| 290006778 | 290005142 | 1.7 | 63.2 | Palliative (P) | 2016-02-13 | 2016-02-19 | Capecitabine | N | N | 290020744 | CAPECITABINE + STREPTOZOCIN |
| 290006779 | 290005143 | 2 | 71.9 | null | 2013-10-27 | 2013-10-28 | INTERAACT trial | 02 | N | 290020748 | OXALIPLATIN + RALTITREXED |